NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis

Overview

About this study

The purpose of this study is to examine the effectivenessof intraarticular ketorolac versus intraarticular triamcinolone in treating symptoms of moderate to advanced primary osteoarthritis of the basilar thumb. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

* Adults \> 40 years of age
* Pain at the thumb base brought on by direct pressure (grind test) and with movement
* Pain resistant to previous conservative management with oral analgesics, NSAIDs, icing, and splinting
* Radiological observation indicative of arthritis based on the Eaton-Littler classification system (stages 1 through 4)
* Patient could understand the protocol and signed the informed consent
* Patient was covered by health insurance

Exclusion Criteria:

* Known allergy to either of the treatment products
* Patient's analgesic treatment regimen was modified within four weeks before trial inclusion
* Scaphoid-trapezial arthritis present
* Localized or systemic infection
* Previous thumb surgery on study thumb
* Previous thumb injury on study thumb
* Patient with inflammatory arthritis (e.g., rheumatoid arthritis, psoriatic arthritis)
* Severe and/or uncontrolled hypertension
* De Quervain tendinopathy present
* Previous injections to the trapeziometacarpal joint on study thumb
* Uncontrolled diabetes
* Pregnant or lactating females
* Immunodeficient patients
* Patients that are currently using nicotine products, or who have quit in the last 12 months
* Patients under guardianship, curatorship, or are otherwise not self-sufficient
* Patients participating in another clinical research trial which interferes with this study protocol or outcomes
* Patients unable to follow the protocol in the investigators' judgement.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 6/25/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Marco Rizzo, M.D.

Open for enrollment

Contact information:

Marco Rizzo M.D.

(507) 284-6434

Rizzo.Marco@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20548341

Mayo Clinic Footer